Dermatology Times: May 4, 2025

123456789101112
Across
  1. 3. A recent article highlighted the long-term psychosocial burden experienced by survivors of this late-stage skin cancer.
  2. 5. Targeting this receptor may enhance next-generation eczema therapies by acting upstream of cytokines.
  3. 6. Q32 Bio’s investigational drug received FDA Fast Track designation for treating alopecia areata.
  4. 8. Along with botulinum toxin A, this substance helped improve skin texture by reducing acne-related pores.
  5. 10. This diagnostic test outperformed CP-GEP in identifying patients who may safely skip sentinel lymph node biopsy.
  6. 11. Multimodal imaging found that this structural protein varies depending on the phenotype of skin photoaging.
Down
  1. 1. This IL-23 inhibitor showed high effectiveness in treating moderate to severe plaque psoriasis in a Korean real-world study.
  2. 2. Two dosing regimens of this oral retinoid were explored for treating recalcitrant facial flat warts.
  3. 4. OCT and D-OCT imaging revealed distinct patterns in this type of skin damage caused by chronic sun exposure.
  4. 7. This non-invasive physical stimulus was shown to enhance wound healing and tissue regrowth.
  5. 9. This gene therapy became the first FDA-approved treatment for recessive dystrophic epidermolysis bullosa.
  6. 12. (Abbreviation) The "Hats On" campaign raises awareness for this precancerous skin condition.